Confirmatory diagnosis of prion diseases in humans and animals relies on the histopathological examination and immunodetection of the protease-resistant isoform of prion protein (PrP res ). The generation of novel PrP-specific monoclonal antibodies (MAbs) has greatly improved diagnostic methodology and basic research on prion diseases as well. In this study, the performance of 3 different PrP-specific MAbs in recognizing brain PrP res deposits from cows affected with bovine spongiform encephalopathy (BSE) was compared by using a standard immunohistochemical technique under different pretreatment conditions. All antibodies showed similar reactivity after denaturing treatment. However, greater differences were found among them after proteinase K treatment, even in the absence of a denaturing step. In fact, 1 MAb (2A11) was able to react with PrP res deposits in the absence of a denaturing step, yielding the strongest signal and confirming the usefulness of MAb 2A11 in immunohistochemistry for the diagnosis of BSE.
Transmissible spongiform encephalopathies (TSEs), also known as prion diseases, belong to a new class of infectious disorders affecting both humans and animals. 20 Among prion diseases, bovine spongiform encephalopathy (BSE) has become a serious public health concern after a link was established between the emergence of a new variant of Creutzfeld-Jakob disease in humans and dietary exposure to BSE-contaminated food. 4 From the appearance of the first BSE case to the adoption of control and surveillance measures, the epidemic reached a peak of more than 170,000 confirmed cases, mostly in the United Kingdom and other European countries. 1 Because of the adoption of rapid postmortem immunoassays, the risk of beef and other products from BSE-infected cattle entering into the human food chain has been considerably reduced. To date, all validated assays rely on immunological detection of prion protein (PrP) by using specific antibodies. 2 Immunohistochemical staining of the protease-resistant isoform of PrP (PrP res ) in brain-tissue sections and Western blot analysis of brain tissue are well-established techniques for the confirmatory diagnosis of TSEs. 15, 21, 22 The accumulation of a PrP res in the central nervous system, together with lymphoid tissues in sheep scrapie, is the key pathological feature of TSEs, and, according to the prion theory, this abnormal isoform is the infectious agent. 20 ies have been recently shown to discriminate between normal and pathological isoforms, 6, 19 there are no PrP res -specific antibodies for immunohistochemistry. 21 The specificity and sensitivity of PrP res detection by immunohistochemistry are greatly affected by the methodology and the PrP antibody used. 11 In this study, 3 different monoclonal antibodies (MAbs) were compared for use in immunohistochemical staining of brainstem samples from BSE-affected cattle under different conditions. Monoclonal antibodies 6H4 a and L42 b were purchased, whereas MAb 2A11 was previously generated in the author's laboratory. 5 All 3 MAbs were of IgG1 isotype, kappa light chain, and had been generated by immunization of PrP knockout mice with recombinant full-length bovine PrP as immunogen. The epitopes recognized by all 3 MAbs are located between amino acid residues 150 and 170 of the PrP (Fig. 1) .
Samples from 10 naturally BSE-affected cows slaughtered during the clinical stage of the disease were used. Brainstem samples containing obex and pontine area were fixed in 10% buffered formalin for 2 weeks. For histopathological and immunohistochemical examinations, the fixed tissue samples were cut into blocks (3-5-mm thick), immersed in 98-100% formic acid c for 1 hour to reduce infectivity, 3 washed in water for 10-15 minutes, dehydrated, and embedded in paraffin wax according to standard histopathological methods. Sections (3 m) were placed on slides treated with 3-triethoxysilyl propilamine c and dried for 24 hours at 37ЊC. The sections were dewaxed by standard procedures and stained with hematoxylin and eosin or used for immunohistochemistry. The following pretreatments or combinations were used for immu- nolabeling: 1) Formic acid: sections were immersed a second time in 98-100% formic acid for 15 minutes followed by rinsing in tap water for 10 minutes and washing in phosphate-buffered saline (PBS) (pH 7.2). This pretreatment was performed for all slides to ensure the reduction of infectivity. 3 2) Proteinase K: sections were immersed in tris-buffered saline (TBS; 50 mM Tris-HCl, 150 mM NaCl, pH 7.6) containing 20 g/ml of proteinase K d for 15 minutes at 37ЊC followed by thorough TBS washing. 3) Guanidine isothiocyanate: sections were immersed in 4 M guanidine isothiocyanate e for 2 hours at 4ЊC. 4) Guanidine isothiocyanate treatment followed by proteinase K digestion as above. Untreated sections were also used for immunolabeling.
Sections were incubated overnight at 4ЊC in a humid chamber with each primary antibody. Antibodies were diluted (1:400) in PBS containing normal goat serum 10%. The immunolabeling of sections was visualized by the avidin-biotin-peroxidase complex method Vectastain Elite Kit f and 3,3Ј-diaminobenzidine tetrahydrochloride e as a chromogen, according to the manufacturers' instructions. The slides were counterstained with Mayer hematoxylin for 1 minute, dehydrated, and routinely mounted. Specific primary antibody was replaced by PBS or nonimmune mouse serum in tissue sections used as negative controls.
Histopathological findings in BSE-infected animals consisted of spongiosis and neuronal vacuolation in different areas of the brainstem. These findings were consistent with BSE. Deposition of PrP res was detected in the medulla oblongata and pontine area of BSEaffected cows with all 3 MAbs (Fig. 2) . Immunostaining was concentrated within specific brain nuclei such as tractus spinalis nucleus and dorsal motor nucleus of the vagus nerve. Positive reaction was observed as granular labeling of the gray mater neuropil as well as granular and spot-like intracellular and extracellular labeling. The majority of PrP res immunoreactivity consisted of aggregates adjacent to or surrounding glial cell nuclei and punctate immunostaining within or around the periphery of the neuronal perikarya. Table 1 summarizes the immunolabeling results.
The MAb 2A11 did not need denaturing pretreatment with guanidine isothiocyanate to detect PrP res reactivity, but proteinase K treatment was particularly effective in enhancing PrP res immunolabeling (Fig. 2) . In contrast, MAbs 6H4 and L42 did not show any positive immunostaining when no pretreatment was used. All 3 antibodies showed very similar results with the combination of formic acid and guanidine isothiocyanate. In contrast to what was observed for MAb 2A11, no differences in the immunoreactivity of 6H4 and L42 were observed after the proteinase K and the guanidine isothiocyanate treatments. Samples from healthy animals did not show any PrP res -like immunoreaction in any area of the brainstem. Sections incubated with PBS or nonimmune mouse serum did not produce any staining. Immunohistochemical staining is widely used for the diagnosis and pathogenesis studies of TSEs. 9, [11] [12] [13] [15] [16] [17] 22 It is also a very useful technique for autolyzed tissues, which may not be suitable for routine histopathology. 8, 18 An adequate number of antibodies have been developed and tested for use in immunohistochemical detection. 11, 14 The normal isoform of PrP (PrP C ) is a very labile protein that can be preserved only with special and careful methods of fixation and embedding. 10 However, PrP res is much more stable and remains immunoreactive after routine fixation in 10% formalin and paraffin embedding. 10 The principal function of antigen-retrieval methods is to unmask antigens after fixation. Enzymatic digestion with proteinase K destroys PrP C ; formic acid, guanidine isothiocyanate, and autoclaving may also destroy the instable PrP C but preserve the detection of PrP res . 7 In the present study, the efficacy of antigen-retrieval methods in the immunohistochemical diagnosis of BSE by using 3 MAbs was evaluated. The procedure included immersion of the brain-tissue block in formic acid to inactivate infectivity. 3 The MAbs, unlike polyclonal antibodies, 11 did not produce any nonspecific background staining. The major difference among the 3 MAbs tested was that the immunoreactivity of MAb 2A11 did not require an initial denaturation step with guanidine isothiocyanate. However, proteinase K enhanced specific immunoreaction. Increased immunoreactivity of the MAb 2A11 after proteinase K treatment has also been observed by Western blot. 5 The particular behavior of MAb 2A11 may be explained by optimal exposure of the PrP-specific epitope after proteinase K digestion of PrP res aggregates. In contrast, MAbs 6H4 and L42 showed no increased reactivity after proteinase K treatment and needed guanidine isothiocyanate treatment to obtain positive results.
The results herein indicate that MAb 2A11 yielded the strongest signal in all cases. As expected, 5 only MAb 2A11 immunoreactivity was greatly enhanced after treatment with proteinase K. These results confirm the usefulness of MAb 2A11 in immunohistochemistry for the diagnosis of BSE.
